These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1044 related items for PubMed ID: 17265428

  • 1. Mechanical stress-mediated Runx2 activation is dependent on Ras/ERK1/2 MAPK signaling in osteoblasts.
    Kanno T, Takahashi T, Tsujisawa T, Ariyoshi W, Nishihara T.
    J Cell Biochem; 2007 Aug 01; 101(5):1266-77. PubMed ID: 17265428
    [Abstract] [Full Text] [Related]

  • 2. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway.
    Hsu YL, Kuo PL.
    J Bone Miner Res; 2008 Jun 01; 23(6):949-60. PubMed ID: 18269307
    [Abstract] [Full Text] [Related]

  • 3. Ugonin K promotes osteoblastic differentiation and mineralization by activation of p38 MAPK- and ERK-mediated expression of Runx2 and osterix.
    Lee CH, Huang YL, Liao JF, Chiou WF.
    Eur J Pharmacol; 2011 Oct 15; 668(3):383-9. PubMed ID: 21806985
    [Abstract] [Full Text] [Related]

  • 4. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, Goto J, Yamamura M, Makino H.
    J Endocrinol; 2008 Mar 15; 196(3):601-13. PubMed ID: 18310456
    [Abstract] [Full Text] [Related]

  • 5. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL, Hsu YL, Chang CH, Chang JK.
    J Pharmacol Exp Ther; 2005 Sep 15; 314(3):1290-9. PubMed ID: 15956019
    [Abstract] [Full Text] [Related]

  • 6. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression.
    Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D.
    Cancer Res; 2006 Feb 01; 66(3):1320-6. PubMed ID: 16452185
    [Abstract] [Full Text] [Related]

  • 7. Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2.
    Fan X, Rahnert JA, Murphy TC, Nanes MS, Greenfield EM, Rubin J.
    J Cell Physiol; 2006 May 01; 207(2):454-60. PubMed ID: 16419041
    [Abstract] [Full Text] [Related]

  • 8. NMDA enhances stretching-induced differentiation of osteoblasts through the ERK1/2 signaling pathway.
    Li JL, Cui B, Qi L, Li XY, Deng LF, Ning G, Liu JM.
    Bone; 2008 Sep 01; 43(3):469-75. PubMed ID: 18573356
    [Abstract] [Full Text] [Related]

  • 9. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK.
    Lee HW, Suh JH, Kim HN, Kim AY, Park SY, Shin CS, Choi JY, Kim JB.
    J Bone Miner Res; 2008 Aug 01; 23(8):1227-37. PubMed ID: 18410224
    [Abstract] [Full Text] [Related]

  • 10. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation.
    Katz S, Boland R, Santillán G.
    Int J Biochem Cell Biol; 2006 Aug 01; 38(12):2082-91. PubMed ID: 16893669
    [Abstract] [Full Text] [Related]

  • 11. Osteogenic response of mesenchymal stem cells to continuous mechanical strain is dependent on ERK1/2-Runx2 signaling.
    Zhang P, Wu Y, Jiang Z, Jiang L, Fang B.
    Int J Mol Med; 2012 Jun 01; 29(6):1083-9. PubMed ID: 22407386
    [Abstract] [Full Text] [Related]

  • 12. Extracellular nucleotides activate Runx2 in the osteoblast-like HOBIT cell line: a possible molecular link between mechanical stress and osteoblasts' response.
    Costessi A, Pines A, D'Andrea P, Romanello M, Damante G, Cesaratto L, Quadrifoglio F, Moro L, Tell G.
    Bone; 2005 Mar 01; 36(3):418-32. PubMed ID: 15777650
    [Abstract] [Full Text] [Related]

  • 13. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
    Datta NS, Chen C, Berry JE, McCauley LK.
    J Bone Miner Res; 2005 Jun 01; 20(6):1051-64. PubMed ID: 15883646
    [Abstract] [Full Text] [Related]

  • 14. Effects of low-intensity pulsed ultrasound on the differentiation of C2C12 cells.
    Ikeda K, Takayama T, Suzuki N, Shimada K, Otsuka K, Ito K.
    Life Sci; 2006 Oct 12; 79(20):1936-43. PubMed ID: 16846618
    [Abstract] [Full Text] [Related]

  • 15. Hydrostatic pressures promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved.
    Liu J, Zhao Z, Li J, Zou L, Shuler C, Zou Y, Huang X, Li M, Wang J.
    J Cell Biochem; 2009 May 15; 107(2):224-32. PubMed ID: 19259952
    [Abstract] [Full Text] [Related]

  • 16. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
    Ali MM, Yoshizawa T, Ishibashi O, Matsuda A, Ikegame M, Shimomura J, Mera H, Nakashima K, Kawashima H.
    J Cell Sci; 2007 Aug 01; 120(Pt 15):2565-73. PubMed ID: 17623776
    [Abstract] [Full Text] [Related]

  • 17. Saponins from the roots of Platycodon grandiflorum stimulate osteoblast differentiation via p38 MAPK- and ERK-dependent RUNX2 activation.
    Jeong HM, Han EH, Jin YH, Hwang YP, Kim HG, Park BH, Kim JY, Chung YC, Lee KY, Jeong HG.
    Food Chem Toxicol; 2010 Dec 01; 48(12):3362-8. PubMed ID: 20828597
    [Abstract] [Full Text] [Related]

  • 18. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2.
    Kilpatrick LE, Sun S, Mackie D, Baik F, Li H, Korchak HM.
    J Leukoc Biol; 2006 Dec 01; 80(6):1512-21. PubMed ID: 17138860
    [Abstract] [Full Text] [Related]

  • 19. Activation of FAK is necessary for the osteogenic differentiation of human mesenchymal stem cells on laminin-5.
    Salasznyk RM, Klees RF, Boskey A, Plopper GE.
    J Cell Biochem; 2007 Feb 01; 100(2):499-514. PubMed ID: 16927379
    [Abstract] [Full Text] [Related]

  • 20. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
    Hanai Y, Tokuda H, Ishisaki A, Matsushima-Nishiwaki R, Nakamura N, Yoshida M, Takai S, Ohta T, Kozawa O.
    Mol Cell Endocrinol; 2006 Jun 07; 251(1-2):42-8. PubMed ID: 16616413
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.